Position in GH
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,654,980
+$735,714 QoQ
Shares Held
11,031
+10.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#273
of 594 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $24,345,955 across 16 Diagnostics & Research names. GH ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,203 | $5,115,376 | |
| 2 | DHR |
Danaher Corp /De/
|
22,681 | $4,320,276 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
7,761 | $4,085,700 | |
| 4 | NTRA |
Natera, Inc.
|
8,565 | $2,324,969 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
11,031 | $1,654,980 | |
| 6 | ILMN |
Illumina, Inc.
|
8,571 | $1,507,038 | |
| 7 | WAT |
Waters Corp /De/
|
3,887 | $1,457,780 | |
| 8 | A |
Agilent Technologies, Inc.
|
5,789 | $768,952 |
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,654,980 | 11,031 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $919,266 | 9,952 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,051,020 | 10,290 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $881,780 | 14,113 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $433,701 | 8,334 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $365,593 | 8,582 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||